Dr. Dietmar Reusch

Characterization Analytics & Development, mAbs
Roche Diagnostics, Germany
After his study of Chemistry with focus on analytics at the University for Applied Science Reutlingen, Germany with a degree as graduate engineer in chemistry, Dietmar was engaged at TÜV Stuttgart as specialist of environmental safety. Since 1988 he is working at Roche Diagnostics. At present Dietmar is heading the Characterization Analytics department of Pharma Development at the Roche facility in Penzberg, Germany. In 2015 he has received his PhD (Glycan analysis of therapeutic antibodies) from the University of Amsterdam. His responsibilities are the characterization and comparability of all large molecules, especially monoclonals in development and production for Roche Pharma Europe. The techniques used in his lab are including mass spectrometry, HPLC-MS, and spectroscopic methods for process development and product release. His special focus is on glycolbiology and glycan analysis with methods like HILIC/RP-UPLC after AB-labeling, HPAEC-PAD, CE and mass spectrometric based methods, including high-throughput techniques.

Events/Masterclasses Dr. Dietmar Reusch is currently speaking at

Pharma

Monoclonal Antibodies
5 - 7 October 2022
Online Live Stream | 13:30 CEST – 17:30 CEST
This unique 3-days course is designed for advanced persons & specialists in the field of protein therapeutics or participants who have emphasis to jump into this new business field.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Dr. Dietmar Reusch
Characterization Analytics & Development, mAbs
Roche Diagnostics, Germany
After his study of Chemistry with focus on analytics at the University for Applied Science Reutlingen, Germany with a degree as graduate engineer in chemistry, Dietmar was engaged at TÜV Stuttgart as specialist of environmental safety. Since 1988 he is working at Roche Diagnostics. At present Dietmar is heading the Characterization Analytics department of Pharma Development at the Roche facility in Penzberg, Germany. In 2015 he has received his PhD (Glycan analysis of therapeutic antibodies) from the University of Amsterdam. His responsibilities are the characterization and comparability of all large molecules, especially monoclonals in development and production for Roche Pharma Europe. The techniques used in his lab are including mass spectrometry, HPLC-MS, and spectroscopic methods for process development and product release. His special focus is on glycolbiology and glycan analysis with methods like HILIC/RP-UPLC after AB-labeling, HPAEC-PAD, CE and mass spectrometric based methods, including high-throughput techniques.
Dr. Dietmar Reusch
Description